Monopar Therapeutics Inc (MNPR) — Financial Flexibility Index
Monopar Therapeutics Inc (MNPR) has a Financial Flexibility Index of -1.63x as of June 2026. Free cash flow of $-6.72 Billion (operating CF $-6.72 Billion minus capex $4.00) represents -2% of total liabilities ($4.12 Billion). Check MNPR intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Monopar Therapeutics Inc Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Monopar Therapeutics Inc across 11 annual periods. For the full cash flow conversion analysis, see Monopar Therapeutics Inc cash conversion from operations.
Annual Financial Flexibility Index for Monopar Therapeutics Inc (2015–2025)
Year-by-year free cash flow to debt coverage for Monopar Therapeutics Inc. Explore Monopar Therapeutics Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.22x | $-12.20 Million | $-12.20 Million | $2.89 Million | ▼ -246.4% |
| 2024 | -1.22x | $-6.40 Million | $-6.40 Million | $5.25 Million | ▲ +72.7% |
| 2023 | -4.47x | $-7.86 Million | $-7.86 Million | $1.76 Million | ▼ -94.1% |
| 2022 | -2.30x | $-7.23 Million | $-7.23 Million | $3.14 Million | ▲ +50.2% |
| 2021 | -4.63x | $-7.32 Million | $-7.32 Million | $1.58 Million | ▼ -16.8% |
| 2020 | -3.96x | $-4.66 Million | $-4.66 Million | $1.18 Million | ▲ +4.9% |
| 2019 | -4.17x | $-3.02 Million | $-3.02 Million | $724.16K | ▲ +42.3% |
| 2018 | -7.23x | $-2.89 Million | $-2.89 Million | $399.55K | ▲ +14.2% |
| 2017 | -8.42x | $-2.63 Million | $-2.63 Million | $311.87K | ▲ +54.5% |
| 2016 | -18.52x | $-1.19 Million | $-1.19 Million | $64.51K | ▼ -114.9% |
| 2015 | -8.62x | $-636.33K | $-636.33K | $73.84K | — |